Patent · US Active

PAR4 agonist peptides

US9605024B2 · kind B2 · utility

4Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 23, 2016
Grant dateMar 28, 2017
Priority date—
Expiry dateFeb 23, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Protease activated receptor 4 (PAR4) agonist peptides are disclosed. These peptides are useful for developing robust PAR4 receptor assays.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.